These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37559401)

  • 21. Topical diphenylcyclopropenone plus topical 0.5% anthralin versus topical diphenylcyclopropenone alone for the treatment of chronic extensive alopecia areata: A split-scalp, double-blind, controlled study.
    Thuangtong R; Suvansuthi S; Maneeprasopchoke P; Sukakul T; Techakajornkeart R; Chaweekulrat P; Wongdama S; Triwongwaranat D
    Int J Trichology; 2022; 14(3):91-96. PubMed ID: 35755959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extensive alopecia areata: not necessarily recalcitrant to therapy!
    Deshpande D; Dhurat R; Saraogi P; Mishra S; Nayak C
    Int J Trichology; 2011 Jul; 3(2):80-3. PubMed ID: 22223966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
    Brown L; Skopit S
    J Drugs Dermatol; 2018 Aug; 17(8):914-917. PubMed ID: 30124734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of topical dithranol (Dithrocream
    Daunton A; Harries M
    Br J Dermatol; 2019 May; 180(5):1246-1247. PubMed ID: 30536990
    [No Abstract]   [Full Text] [Related]  

  • 25. Methotrexate for the treatment of pediatric alopecia areata.
    Landis ET; Pichardo-Geisinger RO
    J Dermatolog Treat; 2018 Mar; 29(2):145-148. PubMed ID: 28627278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Old wine in new bottles: reviving old therapies for alopecia areata using rodent models.
    Tang L; Sundberg JP; Lui H; Shapiro J
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):212-6. PubMed ID: 14582676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study.
    Çerman AA; Solak SS; Altunay İ; Küçükünal NA
    J Drugs Dermatol; 2015 Jun; 14(6):616-20. PubMed ID: 26091388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
    Almutairi N; Nour TM; Hussain NH
    Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
    Kwon O; Senna MM; Sinclair R; Ito T; Dutronc Y; Lin CY; Yu G; Chiasserini C; McCollam J; Wu WS; King B
    Am J Clin Dermatol; 2023 May; 24(3):443-451. PubMed ID: 36855020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is methotrexate an effective and safe treatment for maintaining hair regrowth in people with alopecia totalis? A Critically Appraised Topic.
    Browne R; Stewart L; Williams HC
    Br J Dermatol; 2018 Sep; 179(3):609-614. PubMed ID: 29777625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S; Kim BJ; Lee YB; Lee WS
    JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hair regrowth. Therapeutic agents.
    Shapiro J; Price VH
    Dermatol Clin; 1998 Apr; 16(2):341-56. PubMed ID: 9589208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Methotrexate Combined with Low- to Moderate-Dose Corticosteroids for Severe Alopecia Areata.
    Anuset D; Perceau G; Bernard P; Reguiai Z
    Dermatology; 2016; 232(2):242-8. PubMed ID: 26735937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
    Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing the willingness to undergo treatment in patients with alopecia areata.
    O'Connor LF; Wells KM
    Arch Dermatol Res; 2022 Oct; 314(8):749-757. PubMed ID: 34609599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
    Tosti A; Iorizzo M; Botta GL; Milani M
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topographic Phenotypes of Alopecia Areata and Development of a Prognostic Prediction Model and Grading System: A Cluster Analysis.
    Lee S; Kim BJ; Lee CH; Lee WS
    JAMA Dermatol; 2019 May; 155(5):564-571. PubMed ID: 30916724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alopecia areata. Pathogenesis, diagnosis, and therapy.
    Papadopoulos AJ; Schwartz RA; Janniger CK
    Am J Clin Dermatol; 2000; 1(2):101-5. PubMed ID: 11702308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis.
    Chanprapaph K; Pomsoong C; Kositkuljorn C; Suchonwanit P
    Drug Des Devel Ther; 2022; 16():107-116. PubMed ID: 35027820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.